0000899243-16-025570.txt : 20160722
0000899243-16-025570.hdr.sgml : 20160722
20160722160533
ACCESSION NUMBER: 0000899243-16-025570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160720
FILED AS OF DATE: 20160722
DATE AS OF CHANGE: 20160722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Watler Peter K.
CENTRAL INDEX KEY: 0001622139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 161779779
MAIL ADDRESS:
STREET 1: 235 BERRY STREET, #609
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-20
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001622139
Watler Peter K.
C/O COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
0
1
0
0
Chief Technical Officer
Common Stock, $0.0001 par value
2016-07-20
4
M
0
50000
2.0838
A
50000
D
Common Stock, $0.0001 par value
2016-07-20
4
S
0
50000
25.0242
D
0
D
Common Stock, $0.0001 par value
2016-07-20
4
M
0
23741
1.417
A
23741
I
By Wife
Common Stock, $0.0001 par value
2016-07-20
4
S
0
23741
25.00
D
0
I
By Wife
Stock Option (right to buy)
2.0838
2016-07-20
4
M
0
50000
0.00
D
2022-12-13
Common Stock
50000
92494
D
Stock Option (right to buy)
1.417
2016-07-20
4
M
0
23741
0.00
D
2023-11-21
Common Stock
23741
16247
I
By Wife
The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
The transaction was executed in multiple trades in prices ranging from $25.00 to $25.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person's wife.
All shares underlying this option are vested and exercisable as of the date hereof.
A portion of the shares underlying this option are vested and exercisable as of the date hereof. The original vesting schedule is as follows: The underlying shares subject to the option vest and become exercisable in successive, equal monthly installments over four years measured from July 30, 2013, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
/s/ Jean Frederic Viret, as Attorney-in-Fact for Peter K. Watler
2016-07-22